Medical Office Building Pharmacy is categorized under Hospitals in Minneapolis, MN .
Medical Office Building Pharmacy was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6221100 by the NAICS.
If you are seeking more information, feel free to contact Richard Sturgeon, Chief Executive Officer at the company’s branch by writing to 2545 Chicago Avenue # 120, Minneapolis, Minnesota MN 55404 or by phoning (612) 863-4190. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medical Office Building Pharmacy |
| Contact Person: | Richard Sturgeon, Chief Executive Officer |
| Address: | 2545 Chicago Avenue # 120, Minneapolis, Minnesota 55404 |
| Phone Number: | (612) 863-4190 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6221100 |
| Share This Business: |
Medical Office Building Pharmacy was started in 0 to provide professional Hospitals under the SIC code 8062 and NAICS code 6221100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Richard Sturgeon, Chief Executive Officer for inquiries that concern Medical Office Building Pharmacy by calling the company number (612) 863-4190, as your correspondence is most welcome. Additionally, the physical location of the branch of Medical Office Building Pharmacy can be found at the coordinates 44.95604,-93.26252 as well as the street address 2545 Chicago Avenue # 120 in Minneapolis, Minnesota 55404.
For its online presence, you may visit Medical Office Building Pharmacy’s website at and engage with its social media outlets through on Twitter and on Facebook.